转自：智通财经 【永泰能源：实控人因其涉嫌信披违法违规收到立案告知书】智通财经11月28日电，永泰能源 (600157.SH)公告称，公司董事长、实际控制人王广西收到中国证券监督管理委员会下发的《立案告知 书》，因海南海德资本管理股份有限公司及王广西涉嫌信息披露违法违规，中国证监会决定对其立案。 该立案事项与永泰能源无关，不会影响公司的经营决策和正常生产经营活动。目前公司生产经营正常且 稳定，发展前景良好。 登录新浪财经APP 搜索【信披】查看更多考评等级 ...

Core Viewpoint - The announcement indicates that the major shareholder of Helen Zhe (300201.SZ), Hainan Haide Capital Management Co., Ltd., and its actual controller Wang Guangxi have received a notice of case filing from the China Securities Regulatory Commission (CSRC) due to suspected violations of information disclosure laws [1] Group 1 - The CSRC has decided to file a case against Hainan Haide Capital Management Co., Ltd. and Wang Guangxi on November 28, 2025 [1] - The matters involved in the case filing are unrelated to the company itself [1]

Core Viewpoint - Haosai (002963.SZ) is facing severe challenges due to high judicial risks and ongoing operational losses, compounded by recent legal issues and regulatory scrutiny [1][2]. Group 1: Legal and Regulatory Issues - The China Securities Regulatory Commission (CSRC) has initiated an investigation into Haosai for suspected violations of information disclosure laws [2][4]. - Haosai's former chairman, Dai Baolin, was sentenced to three years in prison (suspended for four years) and fined 3 million yuan for bribery, while the company was fined 7 million yuan for the same offense [2][5]. - The CSRC's investigation follows a warning issued by the Beijing Securities Regulatory Bureau regarding deficiencies in the company's governance and internal controls [9]. Group 2: Financial Performance - Haosai has reported a cumulative net loss of 365 million yuan (approximately 3.65 billion yuan) in net profit after deducting non-recurring gains and losses over the past five years [8][9]. - The company's revenue has significantly declined from 11.57 billion yuan in its first year of listing to 2.65 billion yuan in the first three quarters of 2025, representing a year-on-year decrease of 29.79% [8]. - The net profit for the first three quarters of 2025 showed a loss of 26.31 million yuan, a staggering decline of 523.96% compared to the previous year [8]. Group 3: Management and Control Changes - Dai Baolin resigned as chairman just before his arrest, transferring his voting rights to his son, Dai Congqi, marking a significant change in control amid ongoing legal troubles [7][8]. - The new management under Dai Congqi faces multiple challenges, including unresolved lawsuits, regulatory investigations, and declining performance [7][8].

Core Viewpoint - The article highlights the ongoing strict regulatory environment for listed companies in China's A-share market, with several companies facing administrative penalties or investigations for various violations, including financial misconduct and information disclosure failures [1][2]. Group 1: Regulatory Actions - Multiple A-share companies, including Longbai Group, Dongjiang Environmental Protection, and *ST Chuangxing, have announced administrative penalties due to violations such as false financial reporting and improper disclosure of related party transactions [1][4]. - Over 10 A-share companies have been penalized or investigated in November alone, with a significant number being ST companies, indicating a focused regulatory crackdown [1][2]. Group 2: Specific Company Cases - Longbai Group's subsidiary was fined 1.49 million yuan for a safety incident that resulted in casualties and economic losses, while Dongjiang's subsidiary faced penalties for tax evasion amounting to 202.42 million yuan [2][3]. - *ST Chuangxing was found to have false financial data in its annual reports and was required to submit a written rectification report, with its former chairman facing criminal charges unrelated to the company [4]. - Other companies like Haosai and Jiyuan Pharmaceutical have also been penalized for failing to disclose related party transactions and other regulatory breaches, with fines totaling millions [6][9]. Group 3: Impact on Market Trust - Regulatory officials emphasize the importance of early detection and strict punishment for problematic companies to protect investors and restore market confidence, particularly for ST companies that are given a one-year observation period for rectification [1].

Core Viewpoint - Haosai (002963.SZ) has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation for suspected violations of information disclosure laws, which the company claims will not significantly impact its operations and management [1][4]. Summary by Sections Investigation Details - The CSRC has initiated an investigation into Haosai for suspected violations of information disclosure laws based on the Securities Law and the Administrative Penalty Law of the People's Republic of China [2]. - In August, Haosai disclosed that its controlling shareholder, Dai Baolin, was arrested for suspected unit bribery, and the company was under investigation for the same reason, leading to a warning letter from the Beijing Securities Regulatory Bureau [2]. Legal Consequences - On November 5, Haosai was sentenced for unit bribery, receiving a fine of 7 million yuan, while Dai Baolin was sentenced to three years in prison with a four-year probation and a fine of 3 million yuan [2]. - The prosecution later deemed the sentence for Dai Baolin as too lenient and decided to appeal [2]. Company Response - Haosai stated in its announcement that its business activities are currently operating normally and that the investigation will not have a significant impact on its operations and management [4]. - Legal experts have expressed skepticism regarding the company's assertion, suggesting that such claims are premature before the CSRC's conclusions [5]. Market Impact - The investigation by the CSRC is likely to negatively affect Haosai's market image and investor confidence, with potential administrative penalties introducing uncertainty to the company's financial status and business development [5]. - The company's statement may be an attempt to stabilize investor sentiment and prevent stock price fluctuations amid the ongoing investigation [5].

Core Viewpoint - Haosai (002963.SZ) has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation for suspected violations of information disclosure laws, which the company claims will not significantly impact its operations and management [1][4]. Summary by Sections Investigation Details - The CSRC has initiated an investigation against Haosai for suspected violations of information disclosure laws based on the Securities Law and the Administrative Penalty Law of the People's Republic of China [2]. - In August, Haosai disclosed that its controlling shareholder, Dai Baolin, was arrested for suspected unit bribery, and the company was under investigation for the same reason, leading to a warning letter from the Beijing Securities Regulatory Bureau [2]. Legal Consequences - On November 5, Haosai announced a first-instance judgment where the company was fined 7 million yuan for unit bribery, and Dai Baolin received a three-year prison sentence with a four-year probation and a fine of 3 million yuan [2]. - The prosecution later deemed the sentence for Dai Baolin as too lenient and decided to appeal [2]. Company’s Position - Haosai stated in its announcement that its business activities are currently operating normally and that the investigation will not have a significant impact on its operations and management [4]. - Legal experts have expressed skepticism regarding the company's assertion, suggesting that such claims are premature before the CSRC's conclusions [5]. Market Impact - The investigation by the CSRC is likely to negatively affect Haosai's market image and investor confidence, with potential administrative penalties introducing uncertainty to the company's financial status and business development [5]. - The company's statement may be an attempt to stabilize investor sentiment and prevent stock price fluctuations amid the ongoing investigation [5].

扬子晚报网11月23日讯(记者范晓林薄云峰)11月21日晚，多家上市公司及相关责任人因涉嫌信息披露违法违规等问题，披露收到监管部门立案告知书、行 政处罚事先告知书或行政处罚决定书的相关公告。 在市场人士看来，集中披露上述公告彰显了监管部门强化执法震慑，对信息披露违法违规行为的"零容忍"态度，有助于持续增强投资者信任和信心。 聚石化学表示，目前公司各项经营活动和业务均正常开展。立案调查期间，公司将积极配合证监会的相关工作，并严格按照相关法律法规和监管要求及时 履行信息披露义务。 豪尔赛（002963）市值24.37亿元。 聚石化学市值26.95亿元。 聚石化学11月21日晚公告称，公司于当日收到证监会下发的《立案告知书》，因公司涉嫌信息披露违法违规，证监会决定对公司立案。 嘉应制药11月21日晚公告称，公司于当日收到广东证监局下发的《行政处罚决定书》。 经查明，嘉应制药董事长李能是药聚能的实际控制人，药聚能构成嘉应制药的关联方。2024年10月至2025年1月期间，因药聚能存在短期资金需求，嘉应 制药的子公司湖南嘉应以月初转出、月末转回的方式，向药聚能提供短期资金拆借，单笔发生额在4万元至5999万元之间。其中 ...

Core Points - After nearly six months of investigation, Jiaying Pharmaceutical received a total fine of 4.9 million yuan for information disclosure violations, along with warnings and regulatory actions from the Guangdong Securities Regulatory Bureau and the Shenzhen Stock Exchange [2][5][9] Group 1: Administrative Penalties - The Guangdong Securities Regulatory Bureau issued an administrative penalty decision, imposing a fine of 1.5 million yuan on Jiaying Pharmaceutical, and additional fines on key executives: 1.6 million yuan on Chairman Li Neng, 1 million yuan on General Manager You Yongping, and 800,000 yuan on former CFO Shi Junping, totaling 4.9 million yuan [5][8] - Warnings and regulatory letters were issued to Jiaying Pharmaceutical and its executives, including Li Neng, You Yongping, Shi Junping, and former board secretary Xiao Qiaoxia [5][9] Group 2: Violations and Findings - The investigation revealed that Li Neng, as the actual controller of Hunan Yaojun Pharmaceutical Co., engaged in improper fund transfers between Jiaying Pharmaceutical and its related party, resulting in a total of approximately 220 million yuan in transactions, which accounted for 28.83% of Jiaying Pharmaceutical's latest audited net assets [7][8] - Jiaying Pharmaceutical failed to disclose related party transactions in a timely manner, including transactions with Gonghe Pharmaceutical, which involved approximately 8.76 million yuan, representing 1.15% of the company's latest audited net assets [7][8] Group 3: Additional Regulatory Actions - The Shenzhen Stock Exchange issued a public reprimand against Jiaying Pharmaceutical and its executives, citing violations related to non-operating fund transfers and improper financial assistance [12][13] - Jiaying Pharmaceutical provided a total of 65 million yuan in financial assistance to three non-related companies, with a maximum daily balance of 40 million yuan, which accounted for 5.24% of the company's latest audited net assets [12]

Core Viewpoint - The recent announcements from multiple listed companies regarding regulatory actions highlight the regulatory authorities' zero-tolerance stance towards information disclosure violations, which is expected to enhance investor trust and confidence in the market [1]. Group 1: Regulatory Actions - Several companies received notices from regulatory bodies for suspected violations of information disclosure laws, indicating a crackdown on such practices [1]. - Ju Shi Chemical announced it received a "Notice of Investigation" from the CSRC due to suspected information disclosure violations, stating that its business operations remain normal during the investigation [2]. - Haoer Sai also received a "Notice of Investigation" from the CSRC for similar reasons, affirming that its operations are not significantly impacted by the investigation [2]. Group 2: Administrative Penalties - Jia Ying Pharmaceutical received an administrative penalty decision from the Guangdong Securities Regulatory Bureau, which included a warning and a fine of 1.5 million yuan for failing to disclose related party transactions properly, involving a total of 21.999 million yuan, which constituted 28.83% of its latest audited net assets [3]. - Hengli Industrial, which was delisted in July, received a notice of administrative penalty from the Hunan Securities Regulatory Bureau, proposing a fine of 8 million yuan for false records in its annual reports from 2020 to 2022 [4]. Group 3: Specific Cases of Violations - Zhihua Power's actual controllers and a former executive received a notice of administrative penalty for failing to disclose significant agreements related to share transfers, which involved 5.1% of the company's total shares, amounting to 208.61 million yuan [6][7]. - The Shenzhen Securities Regulatory Bureau proposed a fine of 1.5 million yuan against the actual controllers of Zhihua Power for their failure to disclose the signing of supplementary agreements that significantly impacted the company [8]. - A former vice president of Zhihua Power, Chen Danhua, faced a warning and a proposed fine of 800,000 yuan for violating company law by exceeding the limit on share transfers during a restricted period [9].

Core Viewpoint - Haosai (002963.SZ) has received a notice of investigation from the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, leading to a formal investigation under relevant Chinese laws [1] Financial Performance - In the first three quarters of 2025, Haosai reported a net profit attributable to shareholders of -26.31 million yuan, a year-on-year decline of 523.96% [2] - The net profit attributable to shareholders after excluding non-recurring gains and losses was -31.63 million yuan, a year-on-year decline of 317.90% [2] - From 2021 to 2024, the company's operating revenues were 788 million yuan, 407 million yuan, 538 million yuan, and 459 million yuan respectively [2] - The net profits attributable to shareholders during the same period were 13 million yuan, -156 million yuan, 18 million yuan, and -179 million yuan respectively [2] - The net cash flow from operating activities for the years 2021 to 2024 was 66 million yuan, -165 million yuan, 139 million yuan, and -99 million yuan respectively [2] Initial Public Offering (IPO) Details - Haosai was listed on the Shenzhen Stock Exchange on October 28, 2019, with a public offering of 37.59 million shares at a price of 23.66 yuan per share [1] - The company raised a total of 889 million yuan, with a net amount of 801 million yuan after deducting issuance costs [1] - The funds raised were allocated for various projects, including 650 million yuan for operational funds for engineering projects and 55.52 million yuan for LED lighting R&D [1]